How have CLL shares performed in 2024?

Cello Health plc (CLL.L)'s stock was trading at GBX 161 at the beginning of 2024. Since then, CLL shares have increased by 0.0% and is now trading at GBX 161. View the best growth stocks for 2024 here .

Is Cello Health plc (CLL.L) a good dividend stock?

Cello Health plc (CLL.L) (LON:CLL) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.34%. Read our dividend analysis for CLL .

What other stocks do shareholders of Cello Health plc (CLL.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cello Health plc (CLL.L) investors own include Lloyds Banking Group (LLOY) , Sirius Minerals (SXX) , Saga (SAGA) , QinetiQ Group (QQ) , (OPTR) (OPTR) , Modern Water plc (MWG.L) (MWG) , IGas Energy (IGAS) , 1984318 (IAP.L) (IAP) , Gilead Sciences (GILD) and easyJet (EZJ) .

How do I buy shares of Cello Health plc (CLL.L)?

Shares of CLL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:CLL

Cello Health plc (CLL.L) (CLL) Share Price, News & Analysis

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Free CLL Stock Alerts

GBX 161

0.00 (0.00%)

(As of 08/11/2020)

Compare

Today's Range: 161
▼
161
50-Day Range: 161
▼
161
52-Week Range: 100
▼
165

Volume: N/A
Average Volume: 453,244 shs
Market Capitalization: £178.84 million

P/E Ratio: N/A
Dividend Yield: 1.24%
Price Target: N/A

Stock Analysis

Get Cello Health plc (CLL.L) alerts:

Ad Crypto Swap Profits

Claim Your Complimentary Bitcoin Reward

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

About Cello Health plc (CLL.L) Stock (LON:CLL)

Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment provides market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is headquartered in London, the United Kingdom.

CLL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CLL Stock News Headlines

April 9, 2024 | forbes.com

Best Virtual Therapy Services of 2024

February 15, 2024 | forbes.com

Best Gay Dating Sites Of 2024

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

February 6, 2024 | health.usnews.com

Dr. Patrick L. Cello

January 30, 2024 | morningstar.com

Primary Health Properties PLC

January 5, 2024 | uk.investing.com

Probiotix Health PLC (X90)

December 22, 2023 | forbes.com

Best Low-Carb Diet Meal Delivery Plans of 2023

December 15, 2023 | health.usnews.com

Jessica L. Johnston

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

December 2, 2023 | forbes.com

How Much Do Invisible Braces Cost

November 23, 2023 | forbes.com

Best Dating Sites For Singles Over 50 in 2023

November 1, 2023 | msn.com

Cello World IPO Subscribed 38% On Day 1

October 27, 2023 | bbc.co.uk

The Bee Cello

October 18, 2023 | msn.com

8 Best Cellos for Beginners of 2023

June 23, 2023 | finance.yahoo.com

LTG.L - Learning Technologies Group plc

June 13, 2023 | uk.finance.yahoo.com

PFD.L - Premier Foods plc

May 12, 2023 | investing.com

Trellus Health PLC (TRLST)

May 10, 2023 | investing.com

Rutherford Health PLC (RUTH)

April 8, 2023 | morningstar.com

One Health Group Plc Ordinary Shares

March 26, 2023 | finance.yahoo.com

Q4 2022 Exscientia PLC Earnings Call

March 26, 2023 | seekingalpha.com

Accenture plc 2023 Q2 - Results - Earnings Call Presentation

January 29, 2023 | seekingalpha.com

Wizz Air Holdings Plc 2023 Q3 - Results - Earnings Call Presentation

November 3, 2022 | markets.businessinsider.com

Loxo@Lilly Announces Details of Presentations at the 2022 American Society of Hematology Annual Meeting

September 30, 2022 | thetimes.co.uk

Abel Selaocoe: ‘The cello was a key to a life out of the township’

September 7, 2022 | msn.com

Cello teacher accused of sexually assaulting student

See More Headlines

Receive CLL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cello Health plc (CLL.L) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Business Services
Industry: Marketing Services
Sub-Industry: N/A
Current Symbol: LON:CLL
CUSIP: N/A
CIK: N/A
Web: www.cellogroup.com
Phone: +44-20-78128460
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 14.72
Current Ratio: 1.15
Quick Ratio: 1.11

Sales & Book Value

Annual Sales: £166.77 million
Price / Sales: 1.07
Cash Flow: GBX 8 per share
Price / Cash Flow: 20.13
Book Value: GBX 77.60 per share
Price / Book: 2.07

Miscellaneous

Outstanding Shares: 111,080,000
Free Float: N/A
Market Cap: £178.84 million
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Mark Scott (Age 53)
CEO & Exec. Director
Mr. Mark Bentley (Age 48)
Group Fin. Director, Company Sec. & Exec. Director
Mr. Stephen Highley
Group COO & Director
Mr. Owen Williams
Managing Partner
Mr. Vincent Nolan
Managing Partner

Key Competitors

View All Competitors

CLL Stock Analysis - Frequently Asked Questions

How have CLL shares performed in 2024?: Cello Health plc (CLL.L)'s stock was trading at GBX 161 at the beginning of 2024. Since then, CLL shares have increased by 0.0% and is now trading at GBX 161.
View the best growth stocks for 2024 here.
Is Cello Health plc (CLL.L) a good dividend stock?: Cello Health plc (CLL.L) (LON:CLL) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.34%.
Read our dividend analysis for CLL.
What other stocks do shareholders of Cello Health plc (CLL.L) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cello Health plc (CLL.L) investors own include Lloyds Banking Group (LLOY), Sirius Minerals (SXX), Saga (SAGA), QinetiQ Group (QQ), (OPTR) (OPTR), Modern Water plc (MWG.L) (MWG), IGas Energy (IGAS), 1984318 (IAP.L) (IAP), Gilead Sciences (GILD) and easyJet (EZJ).
How do I buy shares of Cello Health plc (CLL.L)?: Shares of CLL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CLL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial